Patent fight in India centers on AIDS drug

May 11, 2006

A patent application covering tenofovir, a major AIDS drug, has started a major patent fight in India.

If the drug is granted a patent, the manufacture of cheaper versions of tenofovir in India will become illegal, making the drug too expensive for many patients in developing nations, The International Herald Tribune reported Thursday.

The suit challenges Indian patent laws designed to control that country's large pharmaceutical industry, which has long specialized in making cheaper copies of Western manufactured medicines, the newspaper said.

The Indian patent office says it has received about 9,000 patent applications, most from international pharmaceutical companies.

But patient advocates warn the developing world's access to a wide range of vital generic drugs made in India might become jeopardized.

The Delhi Network of Positive People and the Indian Network for People Living with HIV/AIDS filed a formal protest Tuesday to a patent application from U.S.-based Gilead Sciences for the drug tenofovir.

The patient rights group argues tenofovir is not a new drug, just a modified version of an earlier drug, and therefore is not eligible for a new patent under India's laws.

Copyright 2006 by United Press International

Explore further: A touch of frugal genius

Related Stories

A touch of frugal genius

October 15, 2015

A "gutsy" Indian approach to innovation is being echoed worldwide by multinational companies adopting "frugal" approaches that help them do business faster, better and cheaper.

India denies revoking Roche patent, says it lapsed

August 6, 2013

India on Monday denied revoking additional patents related to Roche Holding's breast cancer drug Herceptin, saying the Swiss giant failed to follow legal procedures so the applications lapsed.

EU-India trade deal could limit generics supply

December 10, 2010

(AP) -- AIDS patients in Africa are nervously awaiting the outcome of talks launched Friday between Europe and India on a new trade deal that could slash the world's supply of cheap generics.

Patenting melon juice? Not if India gets its way...

December 11, 2009

Fed up with foreign companies patenting traditional medicine from India, the country's top scientific body is compiling a giant database of everything from yoga positions to medicinal fruit juice.

Recommended for you

Study finds 'rudimentary' empathy in macaques

December 1, 2015

(—A pair of researchers with Centre National de la Recherche Scientifique and Université Lyon, in France has conducted a study that has shown that macaques have at least some degree of empathy towards their fellow ...

Scientists overcome key CRISPR-Cas9 genome editing hurdle

December 1, 2015

Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have engineered changes to the revolutionary CRISPR-Cas9 genome editing system that significantly cut down on "off-target" ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.